A Phase 1 Study of BPX-601 CAR T-Cell Therapy in Adult Participants With Prostate Cancer That Has Returned, is Resistant to Treatment and Has Spread
Clinical trial NCT07543055 · RECRUITING
Trial details
- NCT number
- NCT07543055
- Sponsor
- Regeneron Pharmaceuticals
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-10
- Primary completion
- 2030-02-05
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.